Selexis empowers scientists and biopharmaceutical companies around the world to realize the full potential of their work.

Who we are

Selexis SA is the global leader in mammalian cell line development, providing the highly specialized technology and expertise that are needed to translate scientific innovation into life-saving medicines.

SUREtechnology Platform

With more than 95 partners worldwide, nearly 80 drug candidates in clinical manufacturing, and two commercial products, SUREtechnology has a history of empowering scientists and biopharmaceutical companies around the world to realize the full potential of their research, helping them reach patients with new treatments faster.

LOREM IPSUM

RECENT AND UPCOMING EVENTS

October 31-November 4, 2016
PEGS Europe | Lisbon, Portugal > Speaking, Corporate Sponsor and Exhibitor
Wednesday, November 2 at 12:30 PM “Engineering CHO Cell Lines for Enhanced Robustness”

November 7-9, 2016
BIO Europe | Cologne, Germany > Partnering
Selexis will be participating in partnering meeting.

January 9-13, 2017
PepTalk | San Diego, USA

January 9-13, 2017
J.P. Morgan Healthcare Conference | San Francisco, USA



We are Social